These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33925423)
21. Diagnosis and Treatment of Hereditary Hemorrhagic Telangiectasia. Grigg C; Anderson D; Earnshaw J Ochsner J; 2017; 17(2):157-161. PubMed ID: 28638289 [TBL] [Abstract][Full Text] [Related]
22. Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years. Welle CL; Welch BT; Brinjikji W; Ehman EC; Venkatesh SK; Johnson MP; Iyer VN; Leise MD; Wood CP Abdom Radiol (NY); 2019 Jul; 44(7):2384-2391. PubMed ID: 30888464 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations. de Picciotto C; El Hajjam M; Karam C; Chinet T; Bonay M Respir Res; 2019 Jul; 20(1):137. PubMed ID: 31272464 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients. Brinjikji W; Nasr DM; Wood CP; Iyer VN Cerebrovasc Dis; 2017; 44(3-4):179-185. PubMed ID: 28746925 [TBL] [Abstract][Full Text] [Related]
26. Life experiences of individuals with hereditary hemorrhagic telangiectasia and disclosing outside the family: a qualitative analysis. Higa LA; McDonald J; Himes DO; Rothwell E J Community Genet; 2016 Jan; 7(1):81-9. PubMed ID: 26340858 [TBL] [Abstract][Full Text] [Related]
27. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study. Donaldson JW; McKeever TM; Hall IP; Hubbard RB; Fogarty AW Neurology; 2015 May; 84(18):1886-93. PubMed ID: 25862798 [TBL] [Abstract][Full Text] [Related]
28. The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report. Fanning RP; Strout S; Rowan NR; Weiss CR; Galiatsatos P J Med Cases; 2022 Jun; 13(6):307-311. PubMed ID: 35837077 [TBL] [Abstract][Full Text] [Related]
29. Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia. Mager JJ; Westermann CJ Arch Dermatol; 2000 Jun; 136(6):732-4. PubMed ID: 10871934 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Wang Z; Yang Y; Liang X; Gao B; Liu M; Li W; Chen Z; Wang Z Front Neurol; 2020; 11():571996. PubMed ID: 33193019 [TBL] [Abstract][Full Text] [Related]
32. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Seltzer S Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735 [TBL] [Abstract][Full Text] [Related]
33. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1. Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770 [TBL] [Abstract][Full Text] [Related]
36. High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients. Sivakorn C; Dechsanga J; Jamjumrus L; Boonnak K; Schultz MJ; Dondorp AM; Phumratanaprapin W; Ratanarat R; Naorungroj T; Wattanawinitchai P; Siripoon T; Duangdee C; Techarang T Am J Trop Med Hyg; 2021 May; 105(1):73-80. PubMed ID: 33939645 [TBL] [Abstract][Full Text] [Related]
37. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Osuchowski MF; Winkler MS; Skirecki T; Cajander S; Shankar-Hari M; Lachmann G; Monneret G; Venet F; Bauer M; Brunkhorst FM; Weis S; Garcia-Salido A; Kox M; Cavaillon JM; Uhle F; Weigand MA; Flohé SB; Wiersinga WJ; Almansa R; de la Fuente A; Martin-Loeches I; Meisel C; Spinetti T; Schefold JC; Cilloniz C; Torres A; Giamarellos-Bourboulis EJ; Ferrer R; Girardis M; Cossarizza A; Netea MG; van der Poll T; Bermejo-Martín JF; Rubio I Lancet Respir Med; 2021 Jun; 9(6):622-642. PubMed ID: 33965003 [TBL] [Abstract][Full Text] [Related]
38. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784 [TBL] [Abstract][Full Text] [Related]
39. Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. Jones M; Boisvert A; Landry J; Petrasek PF CMAJ; 2021 Jun; 193(24):E906-E910. PubMed ID: 33990339 [No Abstract] [Full Text] [Related]
40. [Effects of bevacizumab on familial epistaxis caused by hereditary hemorrhagic telangiectasia]. Zhang J; Wang XS; Wang HT Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 56(5):436-441. PubMed ID: 34010995 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]